O'Rourke & Company’s AGNC Investment AGNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$197K Buy
18,070
+194
+1% +$2.04K 0.07% 169
2026
Q1
$179K Buy
17,876
+1,541
+9% +$17K 0.07% 166
2025
Q4
$175K Buy
16,335
+338
+2% +$3.47K 0.07% 162
2025
Q3
$157K Buy
15,997
+414
+3% +$4.01K 0.07% 161
2025
Q2
$143K Buy
15,583
+212
+1% +$1.9K 0.07% 153
2025
Q1
$147K Buy
15,371
+185
+1% +$1.85K 0.07% 149
2024
Q4
$140K Sell
15,186
-2,228
-13% -$21.7K 0.07% 147
2024
Q3
$182K Buy
17,414
+65
+0.4% +$661 0.09% 147
2024
Q2
$166K Sell
17,349
-3,921
-18% -$37.5K 0.09% 141
2024
Q1
$211K Buy
21,270
+2,738
+15% +$26.4K 0.12% 138
2023
Q4
$182K Buy
18,532
+1,019
+6% +$8.96K 0.12% 135
2023
Q3
$165K Buy
17,513
+204
+1% +$2.02K 0.12% 131
2023
Q2
$175K Buy
17,309
+198
+1% +$1.92K 0.12% 132
2023
Q1
$172K Buy
17,111
+4,903
+40% +$53.3K 0.13% 129
2022
Q4
$126K Buy
+12,208
New +$112K 0.1% 132

Other funds holding AGNC

O'Rourke & Company's AGNC Position: Q2 2026 in Review

O'Rourke & Company increased its AGNC Investment (AGNC) stake by 1.1% in Q2 2026, buying an estimated $2.04K and bringing the position to 18,070 shares worth $197K. The position accounts for 0.07% of the portfolio, ranked #169.

O'Rourke & Company first reported a position in AGNC in Q4 2022 and has held it in 15 quarters since. The position peaked at $211K in Q1 2024. 700 funds tracked by Wall St. Rank hold AGNC as of Q2 2026.

  • O'Rourke & Company held 18,070 shares of AGNC Investment worth $197K as of Q2 2026.
  • O'Rourke & Company bought 194 AGNC Investment shares in Q2 2026, an estimated $2.04K.
  • AGNC Investment made up 0.07% of O'Rourke & Company's portfolio in Q2 2026, its #169 holding.
  • O'Rourke & Company first reported a position in AGNC Investment in Q4 2022 and has held it in 15 quarters since.
  • O'Rourke & Company's AGNC Investment position peaked at $211K in Q1 2024.
  • 700 funds tracked by Wall St. Rank held AGNC Investment as of Q2 2026.

Based on O'Rourke & Company's 13F filing for Q2 2026, filed 14 Aug 2026.